Please provide your email address to receive an email when new articles are posted on . A larger lung function improvement was not seen with vs. without antibiotic changes in pulmonary exacerbation ...

Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...

The study, titled “Structural and Functional Pulmonary MRI to Predict Pulmonary Exacerbations in Cystic Fibrosis,” analyzed imaging and clinical data from 106 individuals with CF who were imaged and ...

In patients with cystic fibrosis (CF), the occurrence of pulmonary exacerbations requiring intensive therapy (PERITs) was associated with marked decline in lung function that was not always reversed ...

According to the authors, these findings provide valuable insights for clinicians caring for very young people with cystic fibrosis. Identifying infants at higher risk of early pulmonary exacerbations ...

The ASPEN randomized trial showed that novel brensocatib cut the annualized rate of pulmonary exacerbations by around 20% compared with placebo. Brensocatib is a DPP-1 inhibitor that works by reducing ...

AECOPD is associated with a significant worsening of respiratory symptoms that requires additional therapy. Several studies have indicated that AECOPD increases mortality, morbidity, and overall ...

Evidence suggests higher levels of iron in pulmonary macrophages heightens the risk of infectious exacerbations. A new report yielded fresh insights into the role of pulmonary iron in chronic ...

Bronchiectasis guidelines are inconsistent with regard to the effectiveness of mucoactive agents, and their use varies geographically. Large trials are needed to assess safety and effectiveness. For ...

This longitudinal, historical cohort study conducted within an integrated, not-for-profit HMO examined individuals diagnosed with type 2 diabetes between 1998 and 2008 who developed incident cancer ...